National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

This is VAERS ID 1738747

Government Disclaimer on use of this data



Case Details

VAERS ID: 1738747 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-09-10
Onset:2021-09-12
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-09-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: SARS-CoV-2 test, Temporomandibular joint syndrome
SMQs:, Arthritis (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FLUOXETINE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Depression
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Test Result: Negative ; Comments: No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC202101205329

Write-up: TMJ syndrome; This is a spontaneous report from a contactable consumer. This is a report received from the regulatory Authority report number GB-MHRA-WEBCOVID-202109131539146870-PGX42, Safety Report Unique Identifier GB-MHRA-ADR 25932518. A 25-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 10Sep2021, as a single dose for COVID-19 immunisation. Medical history included depression. The patient has not had symptoms associated with COVID-19 and was not enrolled in clinical trial. The patient was not breastfeeding at the time of this report. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) for depression from an unknown date and unknown if ongoing. On 12Sep2021, 2 days after the vaccination, the patient experienced temporomandibular joint (TMJ) syndrome, reported as serious for being medically significant. On an unknown date, the patient underwent COVID-19 virus test and the result was negative. The patient has not tested positive for COVID-19 since having the vaccine. The clinical outcome of the event TMJ syndrome was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1738747


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166